(S)-1-(5-Chloropyridin-2-yl)ethan-1-amine, 97%, 100mg

4-phenyl-3-(trifluoromethyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 250mg

Sodium bismuthate dihydrate, min. 99%, PA, 50 g, plastic packaging.

(4-Oxo-piperidin-1-yl)-acetic acid hydrochloride, 97%, 250mg

N-(2-(1-(2-((2,3-Dihydro-1H-inden-5-yl)amino)-2-oxoethyl)-1H-benzo[d]imidazol-2-yl)ethyl)-N-methylbenzamide, 98%, 25mg

3-Iodo-1H-indole-5-carbonitrile, 95.0%, 5g

5-Bromo-3-(trifluoromethyl)benzene-1,2-diamine, 97%, 100mg

Barium 4-(phenylamino)benzenesulfonate, 98%, 5g

2-(4-((3-Methoxybenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

4-(aminomethyl)-1-methylpyrrolidin-2-one, 95.0%, 100mg

2,3-Dimethyl-2H-indazol-6-amine dihydrochloride, 98%, 10g

(+)-3,9-Dibromocamphor>97.0%(GC)25g

Methyl 2-(piperidin-4-yl)thiazole-4-carboxylate, 98%, 1g